Polyphase wireless power transfer system achieves 270-kilowatt charge, s...
Scientist-inventors from ORNL will present seven new technologies during the Technology Innovation Showcase on Friday, July 14, from 8 a.m.–4 p.m. at the Joint Institute for Computational Sciences on ORNL’s campus.
ORNL scientists found that a small tweak created big performance improvements in a type of solid-state battery, a technology considered vital to broader electric vehicle adoption.
ORNL will team up with six of eight companies that are advancing designs and research and development for fusion power plants with the mission to achieve a pilot-scale demonstration of fusion within a decade.
A study led by researchers at ORNL could uncover new ways to produce more powerful, longer-lasting batteries and memory devices.
ORNL’s electromagnetic isotope separator, or EMIS, made history in 2018 when it produced 500 milligrams of the rare isotope ruthenium-96, unavailable anywhere else in the world.
Growing up in suburban Upper East Tennessee, Layla Marshall didn’t see a lot of STEM opportunities for children.
“I like encouraging young people to get involved in the kinds of things I’ve been doing in my career,” said Marshall. “I like seeing the students achieve their goals. It’s fun to watch them get excited about learning new things and teaching the robot to do things that they didn’t know it could do until they tried it.”
Marshall herself has a passion for learning new things.
Andrew Lupini, a scientist and inventor at ORNL, has been elected Fellow of the Microscopy Society of America.
Researchers at ORNL have developed a machine-learning inspired software package that provides end-to-end image analysis of electron and scanning probe microscopy images.
Andrew Ullman, Distinguished Staff Fellow at Oak Ridge National Laboratory, is using chemistry to devise a better battery
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.